liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
University of Helsinki, Finland; Helsinki University Hospital, Finland.
Visa övriga samt affilieringar
2017 (Engelska)Ingår i: Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, E-ISSN 1432-1335, Vol. 143, nr 8, s. 1543-1554Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Purpose Tyrosine kinase inhibitors (TKIs) have well-characterized immunomodulatory effects on T and NK cells, but the effects on the humoral immunity are less well known. In this project, we studied TKI-induced changes in B cell-mediated immunity. Methods We collected peripheral blood (PB) and bone marrow (BM) samples from chronic myeloid leukemia (CML) patients before and during first-line imatinib (n = 20), dasatinib (n = 16), nilotinib (n = 8), and bosutinib (n = 12) treatment. Plasma immunoglobulin levels were measured, and different B cell populations in PB and BM were analyzed with flow cytometry. Results Imatinib treatment decreased plasma IgA and IgG levels, while dasatinib reduced IgM levels. At diagnosis, the proportion of patients with IgA, IgG, and IgM levels below the lower limit of normal (LLN) was 0, 11, and 6% of all CML patients, respectively, whereas at 12 months timepoint the proportions were 6% (p = 0.13), 31% (p = 0.042) and 28% (p = 0.0078). Lower initial Ig levels predisposed to the development of hypogammaglobulinemia during TKI therapy. Decreased Ig levels in imatinibtreated patients were associated with higher percentages of immature BM B cells. The patients, who had low Ig levels during the TKI therapy, had significantly more frequent minor infections during the follow-up compared with the patients with normal Ig values (33% vs. 3%, p = 0.0016). No severe infections were reported, except recurrent upper respiratory tract infections in one imatinib-treated patient, who developed severe hypogammaglobulinemia. Conclusions TKI treatment decreases plasma Ig levels, which should be measured in patients with recurrent infections.

Ort, förlag, år, upplaga, sidor
Springer, 2017. Vol. 143, nr 8, s. 1543-1554
Nyckelord [en]
CML; Tyrosine kinase inhibitor; B cell; Immunoglobulin
Nationell ämneskategori
Hematologi
Identifikatorer
URN: urn:nbn:se:liu:diva-139536DOI: 10.1007/s00432-017-2378-6ISI: 000405312900015PubMedID: 28337541Scopus ID: 2-s2.0-85015969804OAI: oai:DiVA.org:liu-139536DiVA, id: diva2:1130072
Anmärkning

Funding Agencies|Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; EUTOS project for CML; Pfizer; Novartis; Bristol-Myers Squibb [NordCML006, NordCML007]

Tillgänglig från: 2017-08-08 Skapad: 2017-08-08 Senast uppdaterad: 2018-04-18Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Lotfi, Kourosh

Sök vidare i DiVA

Av författaren/redaktören
Lotfi, Kourosh
Av organisationen
Avdelningen för läkemedelsforskningMedicinska fakultetenHematologiska kliniken US
I samma tidskrift
Journal of Cancer Research and Clinical Oncology
Hematologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 92 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf